Perucca E, Poitou P, Pifferi G
Department of Internal Medicine and Therapeutics, University of Pavia, Italy.
Eur J Drug Metab Pharmacokinet. 1995 Oct-Dec;20(4):301-5. doi: 10.1007/BF03190249.
The comparative pharmacokinetic and bioavailability profile of two different formulations (tablets and capsules) of thiocolchicoside was investigated in 8 healthy male volunteers after administration of single oral 8 mg doses. Plasma samples were assayed by a capillary gas chromatography--mass spectrometry (GC-MS) method following enzymatic hydrolysis of thiocolchicoside to its aglycone (3-demethylthiocolchicine) and no attempt was made to account for the possible occurrence of hydrolysis in vivo. Irrespective of the formulation used, the drug was rapidly absorbed from the gastrointestinal tract, peak levels of about 17 ng/ml being detected within 1 h in most subjects. Elimination was rapid, with mean MRT values of 5-6 h. All kinetic parameters showed considerable interindividual variability but none differed significantly between the two formulations. Relative to the tablet formulation, the oral bioavailability of the capsule formulation was 1.06 +/- 0.39.
在8名健康男性志愿者单次口服8毫克剂量后,对秋水仙硫胺两种不同剂型(片剂和胶囊)的比较药代动力学和生物利用度特征进行了研究。血浆样品采用毛细管气相色谱 - 质谱联用(GC-MS)法进行测定,测定前秋水仙硫胺经酶水解转化为其苷元(3-去甲基秋水仙碱),且未尝试考虑体内可能发生的水解情况。无论使用哪种剂型,药物均能迅速从胃肠道吸收,大多数受试者在1小时内检测到约17 ng/ml的峰值水平。消除迅速,平均MRT值为5 - 6小时。所有动力学参数均显示出相当大的个体间差异,但两种剂型之间无显著差异。相对于片剂剂型,胶囊剂型的口服生物利用度为1.06±0.39。